These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

893 related items for PubMed ID: 3105322

  • 1. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K, Winberg CD, van de Velde S, Blayney DW, Rappaport H.
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [Abstract] [Full Text] [Related]

  • 2. T-cell-rich lymphoproliferative disorders. Morphologic and immunologic differential diagnoses.
    Winberg CD, Sheibani K, Burke JS, Wu A, Rappaport H.
    Cancer; 1988 Oct 15; 62(8):1539-55. PubMed ID: 2901904
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW, Stoll PN, Shintaku P, Bindl JM, Butmarc JR, Pinkus GS.
    Am J Clin Pathol; 1989 May 15; 91(5):542-9. PubMed ID: 2785753
    [Abstract] [Full Text] [Related]

  • 7. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM, Shahsafaei A.
    Mod Pathol; 1996 Oct 15; 9(10):959-65. PubMed ID: 8902831
    [Abstract] [Full Text] [Related]

  • 8. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR, Fishleder A, Weiss RA, Savage RA, Sebek BA, Weick JK.
    Am J Pathol; 1983 Nov 15; 113(2):207-21. PubMed ID: 6605690
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of Tac antigen by non-Hodgkin's lymphomas.
    Weiss LM, Michie SA, Medeiros LJ, Strickler JG, Garcia CF, Warnke RA.
    Am J Clin Pathol; 1987 Oct 15; 88(4):483-5. PubMed ID: 2821794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS, Said JW.
    Am J Pathol; 1979 Feb 15; 94(2):349-80. PubMed ID: 311589
    [Abstract] [Full Text] [Related]

  • 13. Nodal Involvement by CD30+ Cutaneous Lymphoproliferative Disorders and Its Challenging Differentiation From Classical Hodgkin Lymphoma.
    Lezama LS, Gratzinger D.
    Arch Pathol Lab Med; 2018 Jan 15; 142(1):139-142. PubMed ID: 29257929
    [Abstract] [Full Text] [Related]

  • 14. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC, Jones EL.
    J Pathol; 1979 Dec 15; 129(4):179-90. PubMed ID: 317105
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC, Long JC.
    Am J Med; 1975 Mar 15; 58(3):300-6. PubMed ID: 1090157
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.